a.)

Items of the income statement

34

12,020,532

12,055,355

1.

Net premiums written in the period

24

134,312,438

129,878,160

2.

Investment income (other than financial income)

26

10,175

6,785

3.

Other operating income (excl. revaluation income and releases from provisions) and financial income from operating receivables

27, 28

6,542,519

9,297,168

4.

Net claims payments in the period

29

-77,542,688

-75,354,184

5.

Expenses for bonuses and rebates

85,678

-162,545

6.

Net operating expenses excl. depreciation/amortisation and change in deferred acquisition costs

31

-43,573,077

-43,350,273

7.

Investment expenses (excluding amortisation and financial expenses)

26

-422

-4,454

8.

Other operating expenses excl. depreciation/amortisation (other than for revaluation and excl. additions to provisions)

32

-6,024,419

-6,151,979

9.

Tax on profit and other taxes not included in operating expenses

33

-1,789,671

-2,103,323

b.)

Changes in net operating assets (receivables for premium, other receivables, other assets and deferred tax assets/liabilities) of operating items of the statement of financial position

3,625,406

-643,807

1.

Change in receivables from primary insurance

-85,167,822

0

2.

Change in receivables from reinsurance

8

76,400,625

2,849,455

4.

Change in other receivables and other assets

8

-248,958

-9,830,595

5.

Change in deferred tax assets

3

134,610

912,012

7.

Change in liabilities arising out of primary insurance

51,160,115

0

6.

Change in liabilities arising out of reinsurance business

21

-40,633,836

-4,148,067

7.

Change in other operating liabilities

22

2,168,441

9,571,237

8.

Change in other liabilities (except unearned premiums)

22

-187,768

2,151

c.)

Net cash from/used in operating activities (a + b)

15,645,938

11,411,548

a)

Cash receipts from investing activities

762,460,219

807,729,186

1.

Interest received from investing activities

3,895,945

4,427,975

2.

Cash receipts from dividends and participation in the profit of others

26,755,664

27,051,488

4.

Proceeds from sale of property and equipment

9,879

25,240

5.

Proceeds from sale of financial investments

731,798,731

776,224,483

b)

Cash disbursements in investing activities

-740,531,828

-783,321,091

1.

Purchase of intangible assets

-269,153

-260,516

2.

Purchase of property and equipment

-208,526

-4,152,156

3.

Purchase of financial investments

-740,054,149

-778,908,419

c)

Net cash from/used in investing activities (a + b)

21,928,391

24,408,094

b)

Cash disbursements in financing activities

-38,885,691

-28,115,774

1.

Interest paid

-718,338

-841,834

3.

Repayment of long-term financial liabilities

-24,000,000

0

4.

Repayment of short-term financial liabilities

-1,769,196

-256,421

5.

Dividends and other profit participations paid

-12,398,157

-12,398,157

6.

Treasury share repurchases

0

-14,619,362

c)

Net cash from/used in financing activities (a + b)

-38,885,691

-28,115,774

6,678,458

7,989,819

x)

Net increase/decrease in cash and cash equivalents for the period (Ac + Bc + Cc)

-1,311,361

7,703,869

y)

Opening balance of cash and cash equivalents

7,989,819

285,950